Log in to save to my catalogue

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-r...

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8866359

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

About this item

Full title

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Intensive care medicine, 2022-03, Vol.48 (3), p.311-321

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Insufficient antimicrobial exposure is associated with worse outcomes in sepsis. We evaluated whether therapeutic drug monitoring (TDM)-guided antibiotic therapy improves outcomes.
Methods
Randomized, multicenter, controlled trial from January 2017 to December 2019. Adult patients (
n
 = 254) with sepsis or septic shock were...

Alternative Titles

Full title

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8866359

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8866359

Other Identifiers

ISSN

0342-4642

E-ISSN

1432-1238

DOI

10.1007/s00134-021-06609-6

How to access this item